Carter BZ - Search Results

1

Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia.

Jabbour E, Haddad FG, Sasaki K, Carter BZ, Alvarado Y, Nasnas C, Nasr L, Masarova L, Daver N, Pemmaraju N, Short NJ, Skinner J, Kadia T, Borthakur G, Garcia-Manero G, Ravandi F, Issa GC, Andreeff M, Kantarjian H. Jabbour E, et al. Among authors: carter bz. Cancer. 2024 Apr 9. doi: 10.1002/cncr.35317. Online ahead of print. Cancer. 2024. PMID: 38591430

2

Triptolide induces cell death independent of cellular responses to imatinib in blast crisis chronic myelogenous leukemia cells including quiescent CD34+ primitive progenitor cells.

Mak DH, Schober WD, Chen W, Konopleva M, Cortes J, Kantarjian HM, Andreeff M, Carter BZ. Mak DH, et al. Among authors: carter bz. Mol Cancer Ther. 2009 Sep;8(9):2509-16. doi: 10.1158/1535-7163.MCT-09-0386. Epub 2009 Sep 1. Mol Cancer Ther. 2009. PMID: 19723894 Free PMC article.

3

Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.

Zhou HS, Carter BZ, Andreeff M. Zhou HS, et al. Among authors: carter bz. Cancer Biol Med. 2016 Jun;13(2):248-59. doi: 10.20892/j.issn.2095-3941.2016.0023. Cancer Biol Med. 2016. PMID: 27458532 Free PMC article.

4

Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia.

Wang X, Mak PY, Mu H, Tao W, Rao A, Visweswaran R, Ruvolo V, Pachter JA, Weaver DT, Andreeff M, Xu B, Carter BZ. Wang X, et al. Among authors: carter bz. Mol Cancer Ther. 2020 Aug;19(8):1636-1648. doi: 10.1158/1535-7163.MCT-19-0841. Epub 2020 May 13. Mol Cancer Ther. 2020. PMID: 32404407 Free PMC article.

5

Apoptosis in leukemias: regulation and therapeutic targeting.

Samudio I, Konopleva M, Carter B, Andreeff M. Samudio I, et al. Cancer Treat Res. 2010;145:197-217. doi: 10.1007/978-0-387-69259-3_12. Cancer Treat Res. 2010. PMID: 20306253 Free PMC article. Review.

6

The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it?

Carter BZ, Mak DH, Cortes J, Andreeff M. Carter BZ, et al. Semin Hematol. 2010 Oct;47(4):362-70. doi: 10.1053/j.seminhematol.2010.06.006. Semin Hematol. 2010. PMID: 20875553 Free PMC article. Review.

7

XIAP antisense therapy with AEG 35156 in acute myeloid leukemia.

Katragadda L, Carter BZ, Borthakur G. Katragadda L, et al. Among authors: carter bz. Expert Opin Investig Drugs. 2013 May;22(5):663-70. doi: 10.1517/13543784.2013.789498. Expert Opin Investig Drugs. 2013. PMID: 23586880 Review.

8

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells.

Carter BZ, Mak PY, Mak DH, Ruvolo VR, Schober W, McQueen T, Cortes J, Kantarjian HM, Champlin RE, Konopleva M, Andreeff M. Carter BZ, et al. Oncotarget. 2015 Oct 13;6(31):30487-99. doi: 10.18632/oncotarget.5890. Oncotarget. 2015. PMID: 26431162 Free PMC article.

9

Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells.

Carter BZ, Mak PY, Mu H, Zhou H, Mak DH, Schober W, Leverson JD, Zhang B, Bhatia R, Huang X, Cortes J, Kantarjian H, Konopleva M, Andreeff M. Carter BZ, et al. Sci Transl Med. 2016 Sep 7;8(355):355ra117. doi: 10.1126/scitranslmed.aag1180. Sci Transl Med. 2016. PMID: 27605552 Free PMC article.

10

Eradication of CML stem cells.

Carter BZ, Andreeff M. Carter BZ, et al. Oncoscience. 2016 Nov 23;3(11-12):313-315. doi: 10.18632/oncoscience.327. eCollection 2016. Oncoscience. 2016. PMID: 28105453 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page